X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/05/02/2874176/0/en/Milestone-Pharmaceuticals-Announces-Data-Presentations-on-Etripamil-at-Heart-Rhythm-2024-2024-Stanford-BioDesign-Arrhythmia-Technologies-Retreat-and-ISPOR-2024.html
https://www.globenewswire.com/news-release/2024/04/17/2864436/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-Etripamil-at-the-Preventative-Cardiovascular-Nursing-Symposium.html
https://www.globenewswire.com/news-release/2024/04/08/2859368/0/en/Milestone-Pharmaceuticals-Announces-Etripamil-Data-Demonstrating-Patients-Ability-to-Self-Manage-Recurring-PSVT-Presented-at-The-American-College-of-Cardiology-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/01/2855135/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-Etripamil-at-the-American-College-of-Cardiology-and-European-Heart-Rhythm-Association-Annual-Conferences.html
https://www.globenewswire.com/news-release/2024/03/28/2853852/0/en/Milestone-Pharmaceuticals-Announces-Resubmission-of-New-Drug-Application-for-Etripamil-for-Treatment-in-Paroxysmal-Supraventricular-Tachycardia.html
https://www.globenewswire.com//news-release/2024/02/26/2835011/0/en/Milestone-Pharmaceuticals-Announces-Plan-to-Resubmit-NDA-for-Etripamil-for-the-Treatment-of-PSVT.html
https://www.globenewswire.com/news-release/2023/12/26/2801045/0/en/Milestone-Pharmaceuticals-Receives-Refusal-to-File-Letter-from-U-S-FDA-for-New-Drug-Application-for-Etripamil-in-the-Treatment-of-PSVT.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-presents-positive-results-from-revera-phase-2-study-of-etripamil-in-afib-rvr-at-the-american-heart-association-scientific-sessions-2023-301985199.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-host-investor-and-analyst-webcast-to-review-data-from-revera-phase-2-study-of-etripamil-in-afib-rvr-301979965.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-submission-of-new-drug-application-to-the-us-fda-for-etripamil-301965076.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-publication-of-results-from-phase-3-rapid-clinical-trial-of-etripamil-nasal-spray-in-patients-with-psvt-in-the-lancet-301854596.html
https://www.prnewswire.com/news-releases/selagine-enters-into-a-collaborative-agreement-with-grifols-for-development-and-commercialization-of-immunoglobulin-eye-drops-for-treating-dry-eye-disease-301762822.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-progresses-clinical-and-regulatory-activities-for-etripamil-in-patients-with-paroxysmal-supraventricular-tachycardia-301762828.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-presentation-of-data-from-phase-3-node-302-study-of-etripamil-for-the-treatment-of-psvt-301536657.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-host-virtual-key-opinion-leader-event-on-etripamil-for-the-treatment-of-psvt-301525400.html
https://investors.milestonepharma.com/news-releases/news-release-details/milestone-pharmaceuticals-announces-first-patient-enrolled-rapid
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-regulatory-guidance-and-updated-clinical-development-plan-for-etripamil-in-psvt-301098526.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-topline-results-from-first-of-its-kind-phase-3-node-301-trial-of-etripamil-for-at-home-acute-psvt-treatment-301028371.html
https://endpts.com/four-biotechs-haul-in-303m-from-a-fresh-burst-of-ipos/
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-pricing-of-upsized-initial-public-offering-300846929.html
https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-announces-80-million-private-financing-300737405.html
https://endpts.com/milestone-pharma-grabs-an-80m-round-as-it-steams-into-pivotal-trial-work-starts-outlining-commercial-structure/
https://endpts.com/milestone-pharma-preps-a-leap-into-phiii-cardio-study-with-55m-round-backed-by-novo/
Market Place
Share 
